Poliovirus vaccine live oral monovalent - Panacea Biotec

Drug Profile

Poliovirus vaccine live oral monovalent - Panacea Biotec

Alternative Names: Monovalent oral polio type 1 vaccine; Monovalent oral polio type 2 vaccine; Monovalent oral polio type 3 vaccine; mOPV1 - Panacea Biotec; mOPV2 - Panacea Biotec; mOPV3 - Panacea Biotec; Poliovirus vaccine live oral monovalent type 1; Poliovirus vaccine live oral monovalent type 2; Poliovirus vaccine live oral monovalent type 3

Latest Information Update: 24 Feb 2014

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Panacea Biotec
  • Class Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Market Withdrawal Poliomyelitis

Most Recent Events

  • 24 Feb 2012 Withdrawn for Poliomyelitis (prevention) in India (PO)
  • 01 Nov 2005 Launched for Poliomyelitis (prevention) in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top